miGut-Health receives funding from the Horizon Europe programme. Several other research endeavours have been funded in the same call (HORIZON-HLTH-2022-STAYHLTH-02).
We aim to network and collaborate closely with these sister projects to identify common objectives and strategies, and thus pave the way for a sustainable uptake of results.
AIDA
An Artificially Intelligent Diagnostic Assistant for gastric inflammation
Coordinator
Engineering Ingegneria Informatica SpA, Italy
CARE-IN-HEALTH
CArdiovascularREsolution of INflammation to promote HEALTH
Coordinator
Institut national de la santé et de la recherche médicale, France
ENDOTARGET
Systemic Endotoxemia as the driver of chronic inflammation – Biomarkers and novel therapeutic targets for Arthritis
Coordinator
Helsinki University Hospital, Finland
GlycanTrigger
Glycans as master triggers of health to intestinal inflammation transition
Coordinator
i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
halt-RONIN
Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies
Coordinator
Universidad Complutense de Madrid, Spain
IMMEDIATE
Imminent Disease Prediction and Prevention at the Environment Host Interface
Coordinator
Charité – Universitätsmedizin Berlin, Germany
INITIALISE
Inflammation in human early life: targeting impacts on life-course health
Coordinator
University of Turku, Finland
INTERCEPT-T2D
Early Interception of Inflammatory-mediated Type 2 Diabetes
Coordinator
Institut national de la santé et de la recherche médicale, France
iPROLEPSIS
iPROLEPSIS: psoriatic arthritis inflammation explained through multi-source data analysis guiding a novel personalised digital care ecosystem
Coordinator
Aristotle University of Thessaloniki, Greece
PRAESIIDIUM
physics informed machine learning-based prediction and reversion of impaired fasting glucose management
Coordinator
Spindox Labs, Italy
PREVALUNG EU
Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.
Coordinator
Institute Gustave Roussy, France
PROTO
PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES
Coordinator
Charité – Universitätsmedizin Berlin, Germany